67 related articles for article (PubMed ID: 31445394)
1. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
Han HJ; Seo HH; Han HW; Kim JH
Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9.
Gargano C; Vartanian-Grimaldi JS; Hovhannisyan Y; Joanne P; Agbulut O; Li Z; Parlakian A; Decaux JF
Stem Cell Res; 2023 Dec; 73():103254. PubMed ID: 38035530
[TBL] [Abstract][Full Text] [Related]
3. Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9.
Maierhof SK; Schinke C; Cernoch J; Hew L; Bruske LP; Fernandez Vallone V; Fischer K; Stachelscheid H; Huehnchen P; Endres M; Diecke S; Telugu NS; Boehmerle W
Stem Cell Res; 2023 Dec; 73():103253. PubMed ID: 37984032
[TBL] [Abstract][Full Text] [Related]
4. Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides.
Dong Y; Peng T; Wu W; Tan D; Liu X; Xie D
J Int Med Res; 2019 Apr; 47(4):1717-1730. PubMed ID: 30819013
[TBL] [Abstract][Full Text] [Related]
5. Generation of homozygous and heterozygous REEP1 knockout induced pluripotent stem cell lines by CRISPR/Cas9 gene editing.
Korneck M; Leonhardt A; Schöls L; Hauser S
Stem Cell Res; 2024 Jun; 77():103378. PubMed ID: 38479332
[TBL] [Abstract][Full Text] [Related]
6. Generation of 'designer erythroblasts' lacking one or more blood group systems from CRISPR/Cas9 gene-edited human-induced pluripotent stem cells.
Pandey P; Zhang N; Curtis BR; Newman PJ; Denomme GA
J Cell Mol Med; 2021 Oct; 25(19):9340-9349. PubMed ID: 34547166
[TBL] [Abstract][Full Text] [Related]
7. Generation of heterozygous (MCRIi030-A-1) and homozygous (MCRIi030-A-2) NR2F2/COUP-TFII knockout human iPSC lines.
Ferreira LGA; Cabral-da-Silva MC; Pachernegg S; van den Bergen JA; Robevska G; Vlahos K; Howden SE; Ng ES; Dias-da-Silva MR; Sinclair AH; Ayers KL
Stem Cell Res; 2024 Apr; 76():103374. PubMed ID: 38458031
[TBL] [Abstract][Full Text] [Related]
8. Generation of a PPM1A-deficient human induced pluripotent stem cell line using CRISPR-Cas9 technology.
Guo X; Zhao K; Zhang Y; Zhou T; Pan G
Stem Cell Res; 2024 Jun; 77():103420. PubMed ID: 38643711
[TBL] [Abstract][Full Text] [Related]
9. Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9.
Ratnavadivel S; Dammeier J; Gaertner A; de Toledo MAS; Zenke M; Gummert J; Bloch Rasmussen T; Klinke N; Jürgens K; Meyer H; Paululat A; Milting H
Stem Cell Res; 2024 Apr; 76():103354. PubMed ID: 38430734
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.
Agrawal T; Maddileti S; Mariappan I
Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-mediated gene knockout and interallelic gene conversion in human induced pluripotent stem cells using non-integrative bacteriophage-chimeric retrovirus-like particles.
Mianné J; Nasri A; Van CN; Bourguignon C; Fieldès M; Ahmed E; Duthoit C; Martin N; Parrinello H; Louis A; Iché A; Gayon R; Samain F; Lamouroux L; Bouillé P; Bourdin A; Assou S; De Vos J
BMC Biol; 2022 Jan; 20(1):8. PubMed ID: 34996449
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of GATA6-specific EGFP expressing human induced pluripotent stem cell line, KSCBi017-A-1, using CRISPR/Cas9.
Bayarsaikhan D; Yoo DH; Lee J; Im YS; Bayarsaikhan G; Kang HA; Kim YO; Lee B
Stem Cell Res; 2024 Jun; 77():103426. PubMed ID: 38678980
[TBL] [Abstract][Full Text] [Related]
13. KSCBi005-A-8(hiPSC-PD-L1KO), a PD-L1 knockout human induced pluripotent stem cell line for demonstrating the role of the PD-1/PD-L1 axis.
Han HJ; Kim JH
Stem Cell Res; 2023 Oct; 72():103196. PubMed ID: 37690432
[TBL] [Abstract][Full Text] [Related]
14. KSCBi005-A-10(hiPSC-HIF1αKO), a HIF1α knockout human induced pluripotent stem cell line, for demonstrating the role of cellular response to hypoxia.
Han HJ; Kim JH
Stem Cell Res; 2024 Jun; 77():103415. PubMed ID: 38636267
[TBL] [Abstract][Full Text] [Related]
15. Generation of CRISPR-Cas9 edited human induced pluripotent stem cell line carrying BAG3 V468M mutation in its BAG domain.
Duboscq-Bidot L; Hoareau B; Ader F; Fontaine V; Villard E
Stem Cell Res; 2024 Feb; 74():103294. PubMed ID: 38183888
[TBL] [Abstract][Full Text] [Related]
16. Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A).
Kayser A; Dittmann S; Hamidi J; Laufer SD; Krampe R; Mearini G; Hansen A; Schulze-Bahr E
Stem Cell Res; 2024 Aug; 78():103446. PubMed ID: 38776645
[TBL] [Abstract][Full Text] [Related]
17. Generation of a human induced pluripotent stem cell line JHUi004-A with heterozygous mutation for spinocerebellar ataxia type 12 using genome editing.
Liu HB; Dong T; Deng L; Zhou C; Tang F; Margolis RL; Li PP
Stem Cell Res; 2024 Jun; 77():103441. PubMed ID: 38759410
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of a human iPSC line and gene-corrected isogenic line derived from a patient with a CELF2 gene mutation.
Hua M; Williams L; Burns K; Liu S; Ellis J; Innes AM; McPherson M; Yang G
Stem Cell Res; 2024 Apr; 76():103344. PubMed ID: 38364506
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9-mediated editing of ACTB in induced pluripotent stem cells: A model for investigating human ACTB loss-of-function and genetic adaptive responses.
Binder S; Ramachandran H; Haslinger D; Hildebrandt B; Dobner J; Haarmann-Stemmann T; Chiocchetti A; Rossi A
Stem Cell Res; 2024 Jun; 77():103395. PubMed ID: 38518401
[TBL] [Abstract][Full Text] [Related]
20. Generation of a TRPV1 knockout human pluripotent stem cell line (WAe009-A-U) using CRISPR/Cas9.
Cao Y; Tang L; Su J; Wang H; Liang P; Rong K; Gong T
Stem Cell Res; 2023 Oct; 72():103202. PubMed ID: 37708613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
